ArticlePloS one2026
Impact of age and clinical factors on the feasibility of mobile digital monitoring in people at risk of suicide.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveAssessing the risk of suicidal outcomes is challenging, particularly in older people. Smartphone-based digital phenotyping may help to monitor suicide risk through ecological momentary assessment (EMA) applications. In this real-world study, we investigated if age and other clinical factors were associated with participation in EMA at baseline, and with retention in EMA monitoring among patients at risk of suicide.
methodsParticipation in EMA was determined by quantifying the installation of the MEmind mobile application in individuals involved in the SmartCrisis 1.0 and 2.0 studies. The patients were followed-up over a 6-month period.
resultsN = 512 patients met inclusion criteria, of which 387 installed the MEmind application on their smartphone. While age as a continuous variable was not associated with using EMA at baseline, being aged older than 50 and being engaged in an intimate relationship were independently associated with longer participation in EMA (OR 2.070, 95%CI [1.054-4.066], and OR 2.103, 95%CI [1.076-4.110], respectively). In an exploratory survival analysis, we found that EMA retention increased with age (p < 0.001).
conclusionFeasibility of EMA seems warranted in older people at risk of suicide. Clinicians should be encouraged to offer EMA monitoring to older adults, as they commonly face limitations in their access to healthcare facilities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.